Alveolar Capillary Dysplasia (ACD) is a rare congenital disorder affecting the development of lung blood vessels in newborns. It is not contagious and does not spread from person to person. ACD is caused by genetic mutations and is not influenced by external factors or contact with affected individuals. It is important to consult with healthcare professionals for accurate diagnosis and appropriate management of this condition.
Alveolar Capillary Dysplasia (ACD) is a rare and serious congenital disorder that affects the development of the lungs in newborns. It is characterized by abnormal development of the alveoli (tiny air sacs) and the capillaries (tiny blood vessels) in the lungs. ACD is a genetic condition caused by mutations in the FOXF1 gene.
ACD is not contagious. It is not caused by any infectious agent or exposure to external factors. It is an inherited disorder that is passed down from parents to their children. The condition is usually sporadic, meaning it occurs randomly without any family history, but in some cases, it can be inherited in an autosomal dominant pattern.
ACD is typically diagnosed in newborns who experience severe respiratory distress shortly after birth. The symptoms may include rapid breathing, low oxygen levels, and difficulty maintaining normal blood pressure. Unfortunately, ACD is a life-threatening condition, and most affected infants do not survive beyond the first few months of life.
Due to the genetic nature of ACD, it is important for families with a history of the disorder to seek genetic counseling before planning to have children. Genetic testing can help identify carriers of the FOXF1 gene mutation and provide information about the risk of passing on the condition.